Results 61 to 70 of about 590,891 (162)

Generation and characterization of antagonistic anti-human CD39 nanobodies

Frontiers in Immunology
CD39 is the major enzyme controlling the levels of extracellular adenosine triphosphate (ATP) via the stepwise hydrolysis of ATP to adenosine diphosphate (ADP) and adenosine monophosphate (AMP).
Stephan Menzel, Stephan Menzel, Stephan Menzel, Yinghui Duan, Julia Hambach, Birte Albrecht, Dorte Wendt-Cousin, Riekje Winzer, Eva Tolosa, Anne Rissiek, Anne Rissiek, Andreas H. Guse, Friedrich Haag, Tim Magnus, Friedrich Koch-Nolte, Björn Rissiek   +15 more
doaj   +1 more source

Single domain antibodies in tissue engineering [PDF]

, 2014
The aim of this thesis is to demonstrate the potential of VHH in tissue engineering applications, with a focus on bone and cartilage tissue regeneration. After a general introduction to this thesis in chapter 1, the selection of VHH targeting growth factors is described in chapter 2.
openaire   +2 more sources

Novel human single-domain antibodies exert potent anti-tumor activity by targeting EGF-like repeat epitope of EpCAM

Frontiers in Pharmacology
IntroductionEpCAM (Epithelial cell adhesion molecule) is a key cancer stem cell marker involved in cancer progression, making it an important target for both diagnosis and therapy. Despite efforts using anti-EpCAM monoclonal antibodies (mAbs), their anti-
Xiaofeng Zhou, Zhifang Liu, Weixiong Zhang, Lin Dai, Tao Chen, Zexiong Lin, Hong Pan, Qi Qi, Henry Wei   +8 more
doaj   +1 more source

Single domain antibodies. [PDF]

Lancet (London, England), 1990
openaire   +4 more sources

Preparation of a camel-canine chimeric antibody against canine B-cell lymphoma

AMB Express
Canine B-cell lymphoma is a malignant hematologic neoplastic disease, with diffuse large B-cell lymphoma being the predominant subtype. This subtype highly expresses canine CD20 on its surface.
Baohui Li, Fuxiang Bao, Yanlong Liu, Qihuan Zhao, Puchen Li, Bo Wang, Guanyi Ren, Yu Wang   +7 more
doaj   +1 more source

Editorial: Single-Domain Antibodies—Biology, Engineering and Emerging Applications

Frontiers in Immunology, 2018
Kevin A. Henry, C. Roger MacKenzie, C. Roger MacKenzie   +2 more
doaj   +1 more source

Prediction of antigen-responding VHH antibodies by tracking the evolution of antibody along the time course of immunization

Frontiers in Immunology
Antibody maturation is the central function of the adaptive immune response. This process is driven by the repetitive selection of mutations that increase the affinity toward antigens.
Tomonari Matsuda, Yoko Akazawa-Ogawa, Lilian-Kaede Komaba, Norihiko Kiyose, Nobuo Miyazaki, Yusaku Mizuguchi, Tetsuo Fukuta, Yuji Ito, Yoshihisa Hagihara   +8 more
doaj   +1 more source

Single-domain antibodies for brain targeting

, 2014
Smaller recombinant antibody fragments as single-domain antibodies (sdAbs) are emerging as credible alternatives because of their target specificity, high affinity, and cost-effective recombinant production. sdAbs have been forged into multivalent and multispecif ic therapeutics, or targeting moieties, that are able to shuttle their linked therapeutic ...
Lalatsa, Katerina, Moreira Leite, Diana
openaire   +1 more source

Head-to-head comparison of FAP-targeting single-domain antibody 4AH29 vs. peptide FAP-2286. [PDF]

EJNMMI Res
Dumauthioz N, Navarro L, Berdal M, Nagachinta S, Dewulf J, Van Eesbeek M, Plas S, Pinto J, Antunes ARP, Mantzilas D, D'Huyvetter M.   +10 more
europepmc   +1 more source

Bispecific single-domain antibody (VHH) fused with human IgG1 Fc with dual specificity effectively neutralize Naja Kaouthia venom. [PDF]

PLoS Negl Trop Dis
Pothisamutyothin K, Sathorn S, Boonmee R, Thaveekarn W, Arunmanee W.   +4 more
europepmc   +1 more source